Infrared Sciences has received Food and Drug Administration 510(k) clearance for its BreastScan IR digital infrared imaging system.
Designed to aid in the early detection of breast cancer, BreastScan IR provides doctors with an automated, real-time report for use as an adjunctive test with mammography, ultrasound, or clinical examination, according to the Hauppauge, NY-based firm. Infrared Sciences said it provides BreastScan IR at no up-front cost to qualified doctors, charging a small fee each time the system is used.
By AuntMinnie.com staff writersFebruary 26, 2004
Related Reading
Experimental infrared imager pinpoints tumor development in breast cancer, July 19, 2002
Copyright © 2004 AuntMinnie.com